The enhancement of antitumor antibody binding to cross reactive normal tissue antigens. A complement-mediated effect.
D000818:Animals; D000912:Antibodies, Neoplasm; D000937:Antigen-Antibody Reactions; D000941:Antigens; D003169:Complement Inactivator Proteins; D003165:Complement System Proteins; D003429:Cross Reactions; D007106:Immune Sera; D008223:Lymphoma / Q000276:immunology; D009374:Neoplasms, Experimental / Q000276:immunology; D010527:Perissodactyla / Q000276:immunology; D013154:Spleen / Q000166:cytology
D000912:Antibodies, Neoplasm; D000941:Antigens; D003169:Complement Inactivator Proteins; D007106:Immune Sera; D003165:Complement System Proteins